Diagnostically, liquid biopsies including surface marker and genetic mutations such as MYD88L265P participate in distinguishing WM from B-cell lymphoproliferative disorders as well as from related IgM monoclonal gammopathies. Here, CD40LG is linked to monoclonal gammopathy.